The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient

May 6, 2022 updated by: Darma Putra Sitepu, Dr Cipto Mangunkusumo General Hospital

The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient: a Randomized Clinical Trial

This is a randomized clinical trial to measure the effect of tidal volume (group 6 ml/kg vs 10 ml/kg) on diaphragm dysfunction on mechanically ventilated critical patient.

Study Overview

Status

Active, not recruiting

Detailed Description

Patient was enrolled in the first day receiving mechanical ventilation in ICU. Patient was included to group A or group B. Group A patient will receive tidal volume of 6 ml/kg and group B patient will receive tidal volume of 10 ml/kg. The assignment was randomized. Followed for 3 days. After 24, 48, and 72 hours, patient blood will be collected to measure the interleukin value, and diaphragm dysfunction will be observed by the use of ultrasonography by expert doctor from radiology department. Data will be analyzed statistically if there is an effect of tidal volume difference on diaphragm dysfunction and interleukin-6 as marker of inflammation. The minimal sample of patient is 44 patients.

Study Type

Interventional

Enrollment (Anticipated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Dr Cipto Mangunkusumo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Minimum age 18 years old
  • Critically ill patients

Exclusion Criteria:

  • Patient with ARDS (PaO2/FiO2 <200)
  • Pregnant woman
  • Patient with history of cardiac or thorax surgery 14 days prior to admission
  • Patient with severe peripheral musculoskeletal conditions
  • Patient with prolonged in-hospital stay (>2 weeks) in the last 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: The six
The group who received tidal volume of 6 ml/kg from mechanical ventilation
Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.
ACTIVE_COMPARATOR: The ten
The group who received tidal volume of 10 ml/kg from mechanical ventilation
Tidal volume is defined as the amount of air that moves in or out of the lungs with each respiratory cycle, given by the mechanical ventilator.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DD-24
Time Frame: 24 hours after mechanical ventilation
Diaphragm dysfunction 24 hours after mechanical ventilation assessed by ultrasound.
24 hours after mechanical ventilation
DD-48
Time Frame: 48 hours after mechanical ventilation
Diaphragm dysfunction 48 hours after mechanical ventilation assessed by ultrasound.
48 hours after mechanical ventilation
DD-72
Time Frame: 72 hours after mechanical ventilation
Diaphragm dysfunction 72 hours after mechanical ventilation assessed by ultrasound.
72 hours after mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IL-6-24
Time Frame: 24 hours after mechanical ventilation
Blook interleukin 6 24 hours after mechanical ventilation
24 hours after mechanical ventilation
IL-6-48
Time Frame: 48 hours after mechanical ventilation
Blook interleukin 6 48 hours after mechanical ventilation
48 hours after mechanical ventilation
IL-6-72
Time Frame: 72 hours after mechanical ventilation
Blook interleukin 6 72 hours after mechanical ventilation
72 hours after mechanical ventilation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Discharge outcome
Time Frame: Up to three months after mechanical ventilation
The outcome at hospital discharge (alive or death)
Up to three months after mechanical ventilation
LOS in hospital
Time Frame: Up to three months after mechanical ventilation
Length of stay (days) in hospital
Up to three months after mechanical ventilation
LOS in ICU
Time Frame: Up to three months after mechanical ventilation
Length of stay (days) in ICU
Up to three months after mechanical ventilation
Weaning failure
Time Frame: Up to three months after mechanical ventilation
The condition where patient failed for spontaneous breathing trial after mechanical ventilation. Grouped into success/failed.
Up to three months after mechanical ventilation
Intubation time
Time Frame: At extubation after mechanical ventilation
Time (hours) long when a patient was intubated
At extubation after mechanical ventilation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dita Aditianingsih, Dr, Dr Cipto Mangunkusumo Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2021

Primary Completion (ANTICIPATED)

September 1, 2022

Study Completion (ANTICIPATED)

September 1, 2022

Study Registration Dates

First Submitted

April 28, 2022

First Submitted That Met QC Criteria

May 6, 2022

First Posted (ACTUAL)

May 11, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 11, 2022

Last Update Submitted That Met QC Criteria

May 6, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • DPS1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared since it is belong to the hospital and patient did not consent it to be published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanical Ventilation Complication

Clinical Trials on Tidal volume 6 ml/kg

Subscribe